GOLDEN ARTHUR F 4
4 · Turn Therapeutics Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
GOLDEN ARTHUR F
Director
Transactions
- Purchase
Common Stock
2025-11-21$2.87/sh+20,532$58,927→ 50,734 total
Footnotes (2)
- [F1]Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and the reporting person's continuous service through the vesting date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $3.25, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.